Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and Pazopanib vs Gemcitabine and Docetaxel in Advanced Soft Tissue Sarcoma
NCT01593748Phase 2Completed
- Sponsor
- Medical University of South Carolina
- Start
- Sep 2012
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pazopanib in soft tissue sarcoma (STS), sponsored by Medical University of South Carolina. Started Sep 2012; status: completed.
02
Drugs
pazopanib
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT01593748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01593748.